Design and synthesis of novel 3-amino-5-phenylpyrazole derivatives as tubulin polymerization inhibitors targeting the colchicine-binding site

被引:1
|
作者
Yang, Yang [1 ,3 ]
Cao, Yan [1 ]
Yu, Jingwen [1 ]
Yu, Xinyu [1 ]
Guo, Yali [1 ]
Wang, Fei [1 ]
Ren, Qingjia [2 ]
Li, Caolong [1 ]
机构
[1] China Pharmaceut Univ, Sch Sci, Key Lab Biomed Funct Mat, Nanjing 211198, Peoples R China
[2] Tibetan Tradit Med Coll, Tibetan Med Res Inst, Lasa 850000, Peoples R China
[3] Nantong Univ, Dept Trauma Ctr, Affiliated Hosp, 20 Xisi Rd, Nantong 226001, Jiangsu, Peoples R China
关键词
3-Amino-5-phenylpyrazole derivatives; Tubulin colchicine-binding site; Antiproliferative activity; Antitumor; III BETA-TUBULIN; BIOLOGICAL EVALUATION; PACLITAXEL RESISTANCE; MOLECULAR-MECHANISMS; CANCER-CELLS; AGENTS; DRUGS; MICROTUBULES;
D O I
10.1016/j.ejmech.2024.116177
中图分类号
R914 [药物化学];
学科分类号
100701 ;
摘要
As the basic unit of microtubules, tubulin is one of the most important targets in the study of anticarcinogens. A novel series of 3-amino-5-phenylpyrazole derivatives were designed and synthesized, and evaluates for their biological activities. Among them, a majority of compounds exerted excellent inhibitory activities against five cancer cell lines in vitro. Especially, compound 5b showed a strong antiproliferative activity against MCF-7 cells, with IC50 value of 38.37 nM. Further research indicated that compound 5b can inhibit the polymerization of tubulin targeting the tubulin colchicine-binding sites. Furthermore, 5b could arrest MCF-7 cells at the G2/M phase and induce MCF-7 cells apoptotic in a dose-dependent and time-dependent manners, and regulate the level of related proteins expression. Besides, compound 5b could inhibit the cancer cell migration and angiogenesis. In addition, 5b could inhibit tumor growth in MCF-7 xenograft model without obvious toxicity. All these results indicating that 5b could be a promising antitumor agent targeting tubulin colchicine-binding site and it was worth further study.
引用
收藏
页数:13
相关论文
共 50 条
  • [21] Biologic evaluation of heterocyclic pyrimidines as novel tubulin inhibitors targeting the colchicine binding site
    Arnst, Kinsie
    CANCER RESEARCH, 2018, 78 (13)
  • [22] Optimization of Benzamide Derivatives as Potent and Orally Active Tubulin Inhibitors Targeting the Colchicine Binding Site
    Lin, Songwen
    Du, Tingting
    Zhang, Jingbo
    Wu, Deyu
    Tian, Hua
    Zhang, Kehui
    Jiang, Lin
    Lu, Duo
    Sheng, Li
    Li, Yan
    Ji, Ming
    Chen, Xiaoguang
    Xu, Heng
    JOURNAL OF MEDICINAL CHEMISTRY, 2022, 65 (24) : 16372 - 16391
  • [23] Design and bio-evaluation of novel millepachine derivatives targeting tubulin colchicine binding site for treatment of osteosarcoma
    Geng, Dawei
    Chen, Zhong
    Li, Yin
    Liu, Tianbao
    Wang, Liming
    BIOORGANIC CHEMISTRY, 2024, 151
  • [24] Design, synthesis and biological evaluation of novel tubulin inhibitors targeting colchicine sites
    Yuan, Minghua
    Su, Jingtian
    Zhang, Yixin
    Qin, Jinling
    Yang, Hua
    Duan, Yongtao
    Yao, Yongfang
    Sun, Moran
    BIOORGANIC & MEDICINAL CHEMISTRY LETTERS, 2023, 83
  • [25] Discovery of novel coumarin-based derivatives as inhibitors of tubulin polymerization targeting the colchicine binding site with potent anti-gastric cancer activities
    Tian, Xin-Yi
    Zhang, Wei-Xin
    Chen, Xiao-Yu
    Jia, Mei-Qi
    Zhang, Sai-Yang
    Chen, Yi-Fan
    Yuan, Shuo
    Song, Jian
    Li, Jia
    EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY, 2024, 265
  • [26] Recent Advances in Heterocyclic Tubulin Inhibitors Targeting the Colchicine Binding Site
    Wu, Xiaoxin
    Wang, Qinghui
    Li, Wei
    ANTI-CANCER AGENTS IN MEDICINAL CHEMISTRY, 2016, 16 (10) : 1325 - 1338
  • [27] Tubulin inhibitors targeting the colchicine binding site: a perspective of privileged structures
    Li, Wenlong
    Sun, Honghao
    Xu, Shengtao
    Zhu, Zheying
    Xu, Jinyi
    FUTURE MEDICINAL CHEMISTRY, 2017, 9 (15) : 1765 - 1794
  • [28] Design, Synthesis, in Vitro, and in Vivo Anticancer and Antiangiogenic Activity of Novel 3-Arylaminobenzofuran Derivatives Targeting the Colchicine Site on Tubulin
    Romagnoli, Romeo
    Baraldi, Pier Giovanni
    Salvador, Maria Kimatrai
    Prencipe, Filippo
    Lopez-Cara, Carlota
    Schiaffino Ortega, Santiago
    Brancale, Andrea
    Hamel, Ernest
    Castagliuolo, Ignazio
    Mitola, Stefania
    Ronca, Roberto
    Bortolozzi, Roberta
    Porcu, Elena
    Basso, Giuseppe
    Viola, Giampietro
    JOURNAL OF MEDICINAL CHEMISTRY, 2015, 58 (07) : 3209 - 3222
  • [29] Heterocyclic-Fused Pyrimidines as Novel Tubulin Polymerization Inhibitors Targeting the Colchicine Binding Site: Structural Basis and Antitumor Efficacy
    Banerjee, Souvik
    Arnst, Kinsie E.
    Wang, Yuxi
    Kumar, Gyanendra
    Deng, Shanshan
    Yang, Lei
    Li, Guo-bo
    Yang, Jinbang
    White, Stephen W.
    Li, Wei
    Miller, Duane D.
    JOURNAL OF MEDICINAL CHEMISTRY, 2018, 61 (04) : 1704 - 1718
  • [30] Design, synthesis and biological evaluation of a novel tubulin inhibitor SKLB0565 targeting the colchicine binding site
    Hu, Xi
    Li, Lu
    Zhang, Qiangsheng
    Wang, Qianqian
    Feng, Zhanzhan
    Xu, Ying
    Xia, Yong
    Yu, Luoting
    BIOORGANIC CHEMISTRY, 2020, 97